BTIG Maintains Buy on Boston Scientific, Lowers Price Target to $49
Benzinga Newsdesk 3 days ago
Analyst RatingsNewsPrice TargetHot
BTIG analyst Marie Thibault maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $56 to $49.
BTIG analyst Marie Thibault maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $56 to $49.